In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott licenses rights to 24 drugs from Zydus Cadila

Executive Summary

Indian pharmaco Zydus Cadila has granted Abbott Laboratories Inc. rights to commercialize 24 branded generics in 15 emerging markets (Czech Republic, Egypt, Hungary, Poland, Romania, Russia, Turkey, Brazil, Indonesia, Mexico, Philippines, South Africa, Thailand, Vietnam, and Ukraine). Abbott also gets the option to license 40 other products.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies